Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:54 pm Purchase | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 361,041 13.100% | 20,000 (+5.86%) | Filing History |
| 2022-02-11 4:57 pm Unchanged | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-01-27 11:04 am Sale | 2021-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Davidson Matt | 56,073 2.040% | -88,427 (-61.20%) | Filing History |
| 2021-02-16 8:57 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 341,041 13.200% | 341,041 (New Position) | Filing History |
| 2021-02-16 4:04 pm Purchase | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Paul B Manning | 983,775 38.000% | 19,450 (+2.02%) | Filing History |
| 2021-02-16 3:47 pm Sale | 2020-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Perceptive Advisors LLC | 0 0.000% | -341,041 (Position Closed) | Filing History |